BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 2422488)

  • 1. Circulatory basis for the use of angiotensin converting enzyme inhibitors in hypertension and cardiac failure.
    Robertson JI
    J Cardiovasc Pharmacol; 1986; 8 Suppl 1():S2-8. PubMed ID: 2422488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical use of angiotensin converting enzyme inhibitors in hypertension and cardiac failure.
    Robertson JI; Tillman DM; Herd GW
    Clin Exp Hypertens A; 1987; 9(2-3):489-511. PubMed ID: 3038414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of circulatory-renal limitations to angiotensin-converting enzyme inhibitors identifies patients with severe heart failure and early mortality.
    Kittleson M; Hurwitz S; Shah MR; Nohria A; Lewis E; Givertz M; Fang J; Jarcho J; Mudge G; Stevenson LW
    J Am Coll Cardiol; 2003 Jun; 41(11):2029-35. PubMed ID: 12798577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Angiotensin-converting enzyme inhibition: direct and indirect mechanisms].
    Stumpe KO
    Klin Wochenschr; 1985 Sep; 63(18):897-906. PubMed ID: 2997540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [What have we learned about inhibitors of the renin-angiotensin system?].
    Waeber B; Nussberger J; Brunner HR
    Ann Endocrinol (Paris); 1986; 47(3):167-77. PubMed ID: 3022638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic treatment of hypertensive patients with converting enzyme inhibitors.
    Nussberger J; Biollaz J; Waeber B; Brunner HR
    J Cardiovasc Pharmacol; 1986; 8 Suppl 1():S20-5. PubMed ID: 2422489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Redistribution of regional blood flow following angiotensin-converting enzyme inhibition. Comparison of normal subjects and patients with heart failure.
    Faxon DP; Creager MA; Halperin JL; Bernard DB; Ryan TJ
    Am J Med; 1984 May; 76(5B):104-10. PubMed ID: 6203405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal hemodynamics in essential and renovascular hypertension. Influence of captopril.
    Hollenberg NK
    Am J Med; 1984 May; 76(5B):22-8. PubMed ID: 6328983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restoration of cardiac function and structure by converting enzyme inhibition possibilities and limitations of long-term treatment in hypertension and heart failure.
    Fouad FM; Tarazi RC
    J Cardiovasc Pharmacol; 1986; 8 Suppl 1():S53-7. PubMed ID: 2422493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perindopril.
    O'Loughlin DC; Chu VL; Singh D
    Heart Dis; 2000; 2(6):446-55. PubMed ID: 11728296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal effects of angiotensin converting enzyme inhibitors in hypertension.
    Bauer JH; Reams GP
    Am J Med; 1986 Oct; 81(4C):19-27. PubMed ID: 3022581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitors of the renin-angiotensin system. Effects on blood pressure, aldosterone secretion and renal function.
    Atlas SA; Niarchos AP; Case DB
    Am J Nephrol; 1983; 3(2-3):118-27. PubMed ID: 6191567
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacology of agents acting on the renin-angiotensin system.
    Johnston CI; Jackson B
    Anaesth Intensive Care; 1983 Nov; 11(4):377-83. PubMed ID: 6316803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical pharmacokinetics of the angiotensin converting enzyme inhibitors. A review.
    Kubo SH; Cody RJ
    Clin Pharmacokinet; 1985; 10(5):377-91. PubMed ID: 2994938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haemodynamic responses to specific renin-angiotensin inhibitors in hypertension and congestive heart failure. A review.
    Cody RJ
    Drugs; 1984 Aug; 28(2):144-69. PubMed ID: 6205842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin-converting enzyme inhibitors in hypertension: a review.
    Salvetti A; Pedrinelli R; Arzilli F; Abdel-Haq B; Magagna A; Lucarini A; Graziadei L; Nuccorini A; Taddei S
    Int J Clin Pharmacol Res; 1985; 5(6):429-38. PubMed ID: 3005182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical application of converting enzyme inhibitors.
    Brunner HR; Turini GA; Waeber B; Nussberger J; Biollaz J
    Clin Exp Hypertens A; 1983; 5(7-8):1355-66. PubMed ID: 6315273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical pharmacology of enalapril.
    Gomez HJ; Cirillo VJ; Jones KH
    J Hypertens Suppl; 1983 Oct; 1(1):65-70. PubMed ID: 6100610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enalapril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure.
    Todd PA; Heel RC
    Drugs; 1986 Mar; 31(3):198-248. PubMed ID: 3011386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical utility of angiotensin converting enzyme inhibitors in hypertension.
    Gavras I; Gavras H
    Am J Med; 1986 Oct; 81(4C):28-31. PubMed ID: 3022582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.